EVOME MEDICAL TECHNOLOGIES INC. Quarterly Liabilities and Equity in CAD from Q1 2021 to Q4 2023

Taxonomy & unit
us-gaap: CAD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Evome Medical Technologies Inc. quarterly Liabilities and Equity history and growth rate from Q1 2021 to Q4 2023.
  • Evome Medical Technologies Inc. Liabilities and Equity for the quarter ending December 31, 2023 was CA$48.3M, a 7.29% decline year-over-year.
Liabilities and Equity, Quarterly (CAD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 48.3M -3.79M -7.29% Dec 31, 2023 10-K 2024-04-16
Q3 2023 67.9M +20M +41.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 70.2M +24.7M +54.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 52.9M +10.3M +24.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 52.1M +8.51M +19.5% Dec 31, 2022 10-K 2024-04-16
Q3 2022 47.9M +13.2M +37.8% Aug 31, 2022 10-Q 2022-10-17
Q2 2022 45.4M +10.1M +28.8% May 31, 2022 10-Q 2022-07-15
Q1 2022 42.7M +29.6M +225% Feb 28, 2022 10-KT 2023-04-03
Q4 2021 43.5M Dec 31, 2021 10-KT 2023-04-03
Q3 2021 34.8M Aug 31, 2021 10-Q 2021-10-15
Q2 2021 35.3M May 31, 2021 10-Q/A 2021-08-02
Q1 2021 13.1M Feb 28, 2021 10-K 2022-05-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.